Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aretex Capital Partners is a private equity firm founded in 2018 that focuses on growth-oriented investments and middle-market businesses. The firm partners with entrepreneurs and management teams, providing strategic insight, operational support, and capital for transactions such as growth equity investments, management buyouts, and other complex investments. Aretex is not a drug developer or healthcare operating company; rather, it is a financial sponsor with investments across sectors including business and financial services and selected healthcare-related assets. Its website and third-party profiles indicate operations centered in New York, with a presence in London through its UK management entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aretex Capital Partners.